← 홈

전체 프로그램

ADC 1032 · Antibody 4684 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 31일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,531개
CGTBiologicstaleCancer Institute and Hospital, …Phase 2

Meta10-TIL (Meta10-TIL)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleLeman Biotech Co., Ltd.Phase 1

Metabolically Armed BCMA CAR-T cells. (Metabolically Armed BCMA CAR-T cells.)

Multiple Myeloma (MM); Plasma Cell Leukemia (PCL) · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

Metabolically Armed EGFRvIII CAR-T cells (Metabolically Armed EGFRvIII CAR-T cells)

Glioblastoma (GBM) · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
AntibodystaleUniversité Catholique de LouvainApproved

Methotrexate + Infliximab (Methotrexate + Infliximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleAbbViePhase 1

Mirvetuximab + SL-172154 (Mirvetuximab + SL-172154)

Platinum-resistant Ovarian Cancer; Fallopian Tube Cancer · Platinum-resistant Ovarian Cancer

#Platinum-resistantOvarianCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleAbbViePhase 2

Mirvetuximab Soravtansine-gynx (Mirvetuximab Soravtansine-gynx)

Ovary Cancer; Peritoneal Cancer · Ovary Cancer

#OvaryCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleAustralasian Gastro-Intestinal …Phase 3

Mitomycin C; Capecitabine; Bevacizumab (Mitomycin C; Capecitabine; Bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab)

Relapsed/Refractory Multiple Myeloma · FRα

#FR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
CGTBiologicstaleXuzhou Medical UniversityPhase 2

Mixed CAR-T Transfer (Mixed CAR-T Transfer)

Hematopoietic/Lymphoid Cancer · Hematopoietic/Lymphoid Cancer

#HematopoieticLymphoidCancer#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
AntibodystaleNYU Langone HealthPhase 1

nivolumab (Opdivo, Mocetinostat Induction Phase + Ipilimumab + Nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleNYU Langone HealthPhase 1

nivolumab (Opdivo, Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleMethylGene Inc.Phase 2

brentuximab vedotin (Adcetris, Mocetinostat Plus Brentuximab Vedotin)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 1%임상시험 1상태 ACTIVE
CGTBiologicstaleLiqun ZouPhase 1

Modified anti-CD19 CAR T cells (Modified anti-CD19 CAR T cells)

Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 25%임상시험 1상태 ACTIVE
AntibodystaleAssistance Publique Hopitaux De…Phase 2

IPH2201 (Monalizumab, Monalizumab (IPH2201))

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleIstituto Clinico HumanitasPhase 2

anti-NKG2A monoclonal antibody (Monalizumab, Monalizumab (anti-NKG2A monoclonal antibody))

Acute Myeloid Leukaemia; MDS (Myelodysplastic Syndrome) · Acute Myeloid Leukaemia

#AcuteMyeloidLeukaemia#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodyBiologicstaleSWISS BIOPHARMA MED GmbHPhase 1

Monoclonal antibody (Mab, Monoclonal antibody, Monoclonal antibody (Mab) sB24M)

Pyoderma; Pyoderma Gangrenosum · Pyoderma

#Pyoderma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
ADCBiologicstaleThe First Affiliated Hospital o…Phase 1

Monomethyl Auristatin E (MMAE, Monomethyl Auristatin E, Monomethyl Auristatin E (MMAE) / autologous neutrophil biological agents)

Unresectable Pancreatic Cancer · Unresectable Pancreatic Cancer

#UnresectablePancreaticCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystalePresage BiosciencesPhase 1

nivolumab (Opdivo, Motolimod + Nivolumab)

HNSCC · HNSCC

#HNSCC#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleNational Cancer Institute (NCI)Phase 1

Moxetumomab Pasudotox-tdfk (Moxetumomab Pasudotox-tdfk)

Hairy Cell Leukemia · Hairy Cell Leukemia

#HairyCellLeukemia#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstaleImcyse SAPhase 2

Multi-epitope (ME, Multi-epitope, Multi-epitope (ME) T-cell Receptor Alternate Reading Frame Protein (TARP) vaccine)

Prostatic Neoplasms; Neoplasms of Prostate · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 2.4%임상시험 1상태 ACTIVE

132 / 177 페이지

← 이전다음 →